Seroprevalence of COVID-19 Antibodies among Patients with Haemophilia

Chetan  Garg; Sunita  Aggarwal; Sandeep Garg; Praveen Bharti; Rohit Chawla

Chetan Garg Resident Medicine Doctor, Department of Medicine, Maulana Azad Medical College, New Delhi, Delhi, India.
Sunita Aggarwal Director Professor, , Department of Medicine, Maulana Azad Medical College, New Delhi, Delhi, India.
Sandeep Garg Director Professor, Department of Medicine, Maulana Azad Medical College and Associated Hospitals, New Delhi, India.
Praveen Bharti Professor, Department of Medicine, Maulana Azad Medical College, New Delhi, Delhi, India.
Rohit Chawla Professor, Department of Microbiology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India

Keywords: COVID-19, seroprevalence, hemophilia

Abstract

Introduction: COVID-19 has taken over the world like wildfire and has become one of the leading causes of death among infectious diseases. COVID-19 patients have one or more of the following symptoms high-grade fever, dry cough, muscle ache, eneralized fatigue, difficulty breathing, and loss of taste and smell. Age of the patient along with the comorbidities affecting the patient determine the severity.
Method: The place of study was Lok Nayak Hospital located in New Delhi. The type of study was prospective observational. The incorporation of 112 subjects was done for the study on the basis of inclusion criteria. Informed consent was obtained from the patients after which they underwent rigorous history taking, general and systemic examination and relevant investigations. Interpretation and compilation were done with MS Excel (R) Office 365, GraphPad Prism 8.4.2 and Statistical Package for Social Sciences version 25. Seroprevalence was estimated by measuring the COVID-19 antibodies in these patients’ serum with
an ELISA kit.
Results: Seroprevalence in the current study came out to be 13.39%, which was significantly lower as compared to the overall pooled seroprevalence of India. This was due to better knowledge, awareness and care taken by these patients towards the disease during the pandemic times. COVID-19 antibody index was in low ranges in patients with haemophilia (PWH) and further exploration and subsequent seroprevalence studies are needed to monitor the antibody index.
Conclusion: Many factors contribute to the seroprevalence of COVID-19, including demographic profile, occupation, socio-economic status of the country, and personal protective measures taken. Seroprevalence studies are important in making healthcare policies and prioritisation in the early rollout of vaccination for susceptible groups of people and their protection.

How to cite this article:
Garg C, Aggarwal S, Chawla R, Garg S, Bharti P. Seroprevalence of COVID-19 Antibodies among Patients with Haemophilia. J Adv Res Med. 2022;9(4):1-6

DOI: https://doi.org/10.24321/2349.7181.202215

References

Rostami A, Sepidarkish M, Fazlzadeh A, Mokdad AH, Sattarnezhad A, Esfandyari S, Riahi SM, Mollalo A, Dooki ME, Bayani M, Nazemipour M, Mansournia MA, Hotez PJ, Gasser RB. Update on SARS-CoV-2 seroprevalence:

regional and worldwide. Clin Microbiol Infect. 2021 Dec;27(12):1762-71. [PubMed] [Google Scholar]

Robbiani DF, Gaebler C, Muecksch F, Lorenzi JC, Wang Z, Cho A, Agudelo M, Barnes CO, Gazumyan A, Finkin S, Hägglöf T, Oliveira TY, Viant C, Hurley A, Hoffmann HH, Millard KG, Kost RG, Cipolla M, Gordon K, Bianchini F, Chen ST, Ramos V, Patel R, Dizon J, Shimeliovich I, Mendoza P, Hartweger H, Nogueira L, Pack M, Horowitz J, Schmidt F, Weisblum Y, Michailidis E, Ashbrook AW, Waltari E, Pak JE, Huey-Tubman KE, Koranda N, Hoffman

PR, West Jr AP, Rice CM, Hatziioannou T, Bjorkman PJ, Bieniasz PD, Caskey M, Nussenzweig MC. Convergent

antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 Aug;584(7821):437-42. [PubMed] [Google Scholar]

Stephens DS, McElrath MJ. COVID-19 and the path to immunity. JAMA. 2020 Oct 6;324(13):1279-81. [PubMed] [Google Scholar]

Escobar M, Sallah S. Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding

severity and prophylaxis. J Thromb Haemost. 2013 Aug;11(8):1449-53. [PubMed] [Google Scholar]

Fijnvandraat K, Cnossen MH, Leebeek FW, Peters M. Diagnosis and management of haemophilia. BMJ. 2012

May 2;344:e2707. [PubMed] [Google Scholar]

Vinayagam S, Sattu K. SARS-CoV-2 and coagulation disorders in different organs. Life Sci. 2020 Nov 1;260:118431. [PubMed] [Google Scholar]

Murhekar MV, Bhatnagar T, Thangaraj JW, Saravanakumar V, Kumar MS, Selvaraju S, Rade K, Kumar CP, Sabarinathan R, Turuk A, Asthana S, Balachandar R, Bangar SD, Bansal AK, Chopra V, Das D, Deb AK, Devi KR,

Dhikav V, Dwivedi GR, Khan SM, Kumar MS, Laxmaiah A, Madhukar M, Mahapatra A, Rangaraju C, Turuk J,

Yadav R, Andhalkar R, Arunraj K, Bharadwaj DK, Bharti P, Bhattacharya D, Bhat J, Chahal AS, Chakraborty D,

Chaudhury A, Deval H, Dhatrak S, Dayal R, Elantamilan D, Giridharan P, Haq I, Hudda RK, Jagjeevan B, Kalliath A,

Kanungo S, Krishnan NN, Kshatri JS, Kumar A, Kumar N, Kumar VG, Lakshmi GG, Mehta G, Mishra NK, Mitra A,

Nagbhushanam K, Nimmathota A, Nirmala AR, Pandey AK, Prasad GV, Qurieshi MA, Reddy SD, Robinson A,

Sahay S, Saxena R, Sekar K, Shukla VK, Singh HB, Singh PK, Singh P, Singh R, Srinivasan N, Varma DS, Viramgami

A, Wilson VC, Yadav S, Yadav S, Zaman K, Chakrabarti A, Das A, Dhaliwal RS, Dutta S, Kant R, Khan AM, Narain K, Narasimhaiah S, Padmapriyadarshini C, Pandey K, Pati S, Patil S, Rajkumar H, Ramarao T, Sharma YK, Singh S,

Panda S, Reddy DC, Bhargava B; ICMR Serosurveillance Group. SARS-CoV-2 seroprevalence among the general

population and healthcare workers in India, December 2020–January 2021. Int J Infect Dis. 2021 Jul;108:145-

[PubMed] [Google Scholar]

Sharma N, Sharma P, Basu S, Bakshi R, Gupta E, Agarwal R, Dushyant K, Mundeja N, Marak Z, Singh S, Singh G,

Rustagi R. Second wave of the COVID-19 pandemic in Delhi, India: high seroprevalence not a deterrent?

Cureus. 2021;13(10):e19000. [PubMed] [Google Scholar]

Abdel-Moneim AS. Community mitigation during SARSCoV-2 pandemic: mission impossible in developing

countries. Popul Health Manag. 2021 Feb 1;24(1):6-7. [PubMed] [Google Scholar]

Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global pandemic influenza

mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis. Lancet.

Dec;368(9554):2211-8. [PubMed] [Google Scholar]

World Federation of Hemophilia. World Federation of Hemophilia report on the annual global survey 2014.

World Federation of Hemophilia; 2015;(October):54.

Chen X, Chen Z, Azman AS, Deng X, Sun R, Zhao Z, Zheng N, Chen X, Lu W, Zhuang T, Yang J, Viboud C, Ajellu M, Leung DT, Yu H. Serological evidence of human infection with SARS-CoV-2: a systematic review and metaanalysis. Lancet Glob Health. 2021 May;9(5):e598-609. [PubMed] [Google Scholar]

Bobrovitz N, Arora RK, Cao C, Boucher E, Liu M, Donnici C, Yanes-Lane M, Whelan M, Perlman-Arrow S, Chen J, Rahim H, Ilincic N, Segal M, Duarte N, Wyk JV, Yan T, Atmaja A, Rocco S, Joseph A, Penny L, Clifton DA, Williamson T, Yansouni CP, Evans TG, Chevrier J, Papenburg J, Cheng MP. Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and metaanalysis. PLoS One. 2021;16(6):e0252617. [PubMed] [Google Scholar]